Recombinant human TNFRSF7/CD27 protein

Cat No.
ATGP3416

Size

QTY

List Price

10ug

USD 77


20ug

USD 142

50ug

USD 189

100ug

USD 313

250ug

USD 549

500ug

USD 938

1mg

USD 1,564

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
Baculovirus
Domain
21-191aa
UniProt No.
P26842
NCBI Accession No.
NP_001233.1
Alternative names
CD27L receptor, T-cell activation antigen CD27, T14, Tumor necrosis factor receptor superfamily member 7, TNFRSF7, T cell antivation antigen S152, TP55

Product Specification

Molecular Weight
46.4 kDa (413aa)
Concentration
0.5mg/ml (determined by absorbance at 280nm)
Formulation
Liquid in. Phosphate-Buffered Saline (pH 7.4) containing 10% glycerol
Purity
> 85% by SDS-PAGE
Bioactivity
Measured by its binding ability in a functional ELISA with Human CD27 Ligand/TNFSF7 (CAT# ATGP3336). The ED50 range ≤ 0.5 ug/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
hIgG-His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Human CD27 Ligand/TNFSF7 (CAT# ATGP3336) is coated at 10 ug/ml (100 ul/well) can bind Human CD27/TNFRSF7. The ED50 range ≤ 0.5 ug/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.